Background: Epigenetic mechanisms such as DNA methylation play an important role in regulating the pathophysiology of alcoholism. Chronic alcohol exposure leads to behavioral changes as well as decreased expression of genes associated with synaptic plasticity. In the liver, it has been documented that chronic alcohol exposure impairs methionine synthase (Ms) activity leading to a decrease in S-adenosyl methionine/S-adenosyl homocysteine (SAM/SAH) ratio which results in DNA hypomethylation; however, it is not known whether similar alterations of SAM and SAH levels are also produced in brain.
T HE CEREBELLUM IS not only the coordination center for motor learning and control, but also plays a significant role in cognitive processing and sensory discrimination (Martin et al., 1996; Middleton and Strick, 2001 ). In addition, cerebellar involvement in a number of higher-order cognitive functions such as language, visuospatial, executive, and working memory processes has also been demonstrated (Stoodley, 2012) . This brain region is an important target for the toxicity and effects of ethanol (EtOH). In fact, EtOH-induced cerebellar ataxia is one of the most consistent physical manifestations of acute alcohol consumption and appears to underlie an important brain circuit for regulating the consequences of alcohol intoxication (Dar, 2015) . Evidence also suggests that chronic alcohol-induced cerebellar deficits are persistent even after withdrawal from alcohol exposure (Sullivan, 2000; Sullivan et al., 2005) .
Research findings from several laboratories suggest that variation in cerebellar structure and processing, and cerebellar-dependent behavioral sensitivity to EtOH are heritable and associated with susceptibility to alcohol use disorders (AUDs; Cservenka, 2016; Herting et al., 2011; Hill et al., 2001; Schuckit, 1985; Schuckit and Smith, 1996) . In addition, cerebellar-related genetic risk has been demonstrated in studies with a low level of response (LLR) to EtOH phenotype (defined as requiring a higher dose of EtOH to attain a given effect) which is also associated with risk for developing AUD (Schuckit, 2009) . Furthermore, cerebellar LLR phenotype is common in young men and women with a family history of alcohol use disorder (Eng et al., 2005; Schuckit, 1985) and can also predict the risk of developing AUD (Schuckit and Smith, 1996) , while in rodents, this phenotype is common in strains with high EtOH consumption (Gallaher et al., 1996) . In fact, low cerebellar sensitivity to EtOH has been suggested as a risk factor to alcoholism (Kaplan et al., 2013) . Although the molecular mechanism underlying EtOH-induced cerebellar ataxia and alcoholism has been linked to the transcriptional regulation of cAMP response element binding protein (Acquaah-Mensah et al., 2006) , the cellular, biochemical, and molecular mechanisms underlying EtOHinduced cerebellar ataxia and toxicity remain unclear.
Epigenetic mechanisms such as DNA methylation play an important role in regulating the alterations of synaptic plasticity associated with alcoholism and alcohol-drinking behaviors (Krishnan et al., 2014) . Several laboratories have demonstrated that EtOH-induced acute and chronic effects are partly due to its regulatory actions on local and global DNA methylation patterns (Barbier et al., 2015; Wong et al., 2011) . Furthermore, it is believed that the effects of EtOH on DNA methylation are mediated by its interference with the availability of S-adenosyl methionine (SAM), the principal biological methyl donor for all transmethylation reactions (Varela-Rey et al., 2013) . These effects have been well studied in liver tissue where chronic EtOH exposure impairs methionine synthase (Ms) activity leading to decreased conversion of S-adenosylmethionine (SAM) into S-adenosylhomocysteine (SAH) and a decrease in the SAM/ SAH ratio in liver (Ji et al., 2008; Song et al., 2003) . Perturbation of the SAM/SAH ratio brings about alterations of DNA-methyltransferase (Dnmt1, 3a, 3b) activity and DNA methylation which are catalyzed by specific SAM-dependent methyltransferases. These alterations of SAM metabolism lead to a reduction in hepatic DNA methylation capacity which results in the characteristic hallmark features that have been associated with alcohol-induced liver injury (VarelaRey et al., 2013) .
EtOH-mediated alterations of methionine biosynthesis and metabolism ( Fig. 1) are mediated by the inhibition of Ms activity or the activity of other key enzymes of the onecarbon metabolism such as methionine adenosyltransferase (Mat) catalytic (2a) and regulatory (2b) subunits, S-adenosyl homocysteine hydrolase (Ahyc), betaine homocysteine methyltransferase (Bhmt), and methylene tetrahydrofolate reductase (Mthfr) (Ji and Kaplowitz, 2003; Lu et al., 2000; Villanueva and Halsted, 2004; Villanueva et al., 2007) . The mechanisms through which chronic EtOH exposure alters DNA methylation pathways in the brain, and particularly the cerebellum, are still unknown. In addition, it is not known whether the perturbations of methionine metabolism that have been reported in liver tissue following chronic EtOH exposure are also present in brain structures. To the best of our knowledge, there are no studies linking changes in the levels of SAM and SAH or the SAM/SAH ratio in the liver with alterations in DNA methylation patterns in the cerebellum. Thus, we studied the effects of chronic EtOH exposure and its withdrawal on SAM and SAH levels and the expression of some key enzymes involved in one-carbon metabolism in rat cerebellum and compared the observed effects with those occurring in liver tissues of the same animals. We found that chronic EtOH exposure resulted in a decrease in SAM level and the SAM/SAH ratio with a slight increase in SAH levels in liver, whereas in the cerebellum, chronic EtOH elicited an increase in SAM/SAH ratio by decreasing SAH levels with no effect on SAM levels. To the best of our knowledge, this is the first study comparing the effects of chronic EtOH exposure on the regulation of SAM and SAH availability and the SAM/SAH ratio in liver and cerebellum.
MATERIALS AND METHODS

Chronic EtOH Treatment Paradigm
Adult male Sprague Dawley rats (Harlan, Indianapolis, IN) were received, and after 1 week of acclimatization, they were housed individually and maintained on a 12/12-hour light-dark cycle with standard food and water made available ad libitum. All experiments were carried out in accordance with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals and approved by the animal committee at the University of Illinois at Chicago.
Rats were randomly assigned to 3 treatment groups: (i) control diet fed, (ii) EtOH diet fed (0 hour withdrawal), and (iii) EtOH diet fed (24 hours withdrawal) referred to as the EtOH-withdrawn group. The rats were either fed with Lieber-DeCarli control or EtOH liquid diet as previously described (Pandey et al., 2008) . In brief, all 3 groups of rats were exposed to 80 ml/d of nutritionally complete Lieber-DeCarli liquid control diet (Bio-Serv, Frenchtown, NJ) for 3 days. The control group continued with control diet for 16 days, while EtOH-treated groups were gradually introduced to EtOH and then maintained on 9% v/v EtOH diet for 15 to 16 days. EtOH-diet-fed rats were withdrawn for 0 or 24 hours. Rats were pair-fed, and their liquid diet intake and body weight was closely monitored. We and other investigators have used this alcohol treatment paradigm and reported blood EtOH levels in the range of 172 to 198 mg/100 ml for EtOH-diet-fed (0 hour withdrawn) rats, whereas the blood EtOH level after 24 hours of EtOH withdrawal was 0 mg/100 ml (Baldwin et al., 1991; Hunter et al., 1975; Pandey et al., 1992 Pandey et al., , 2008 You et al., 2014) . It is important to point out that we have used the above animal model to establish brain molecular mechanisms of alcohol dependence (Pandey et al., 2008; You et al., 2014) , and other investigators have also used a similar model to investigate mechanisms related to hepatic injury and one-carbon metabolism (Kharbanda et al., 2014) . All rats were euthanized using isoflurane and cerebellum, and liver tissue was dissected and frozen at À80°C until used for real-time quantitative polymerase chain reaction (qPCR) and measurement of SAM and SAH levels.
RNA Extraction
Total RNA was isolated from cerebellum and liver tissues using the TRIzol reagent (Life Technologies 15596-026; Life Technologies Corporation, Carlsbad, CA) and further purified using the Qiagen RNeasy Kit (Valencia, CA).
Real-Time PCR Quantification
Total RNA was converted to cDNA using the Applied Biosystems High Capacity Archive Kit (4368813; Piscataway, NJ). Relative real-time qPCR was performed with the Applied Biosynthesis Real-Time PCR system using Fermentas Maxima SYBR Green/ ROX qPCR Master Mix (K0222; Fermentas International Inc., Pittsburg, PA). PCR mixtures were run on a Stratagene, Mx3005P QPCR System (Santa Clara, CA). Primers were designed to cross over 1 intron to amplify cDNA and yield an amplicon between 124 and 299 base pairs (primer sequences are provided in Table 1 ). Dissociation curves were conducted to establish the presence of a single amplicon at the predicted melting temperature and a lack of primer-dimer formation. A comparative threshold cycle (C T ) validation experiment was carried out to determine target and reference primer efficiency. For normalization of mRNA expression, Gapdh was used as internal control. C T value was used for relative quantification of target gene expression and normalized to Gapdh, and the relative expression levels were calculated as C T (Livak and Schmittgen, 2001 ).
Measurement of SAM and SAH Levels by High-Performance Liquid Chromatography
Rat cerebellum or liver tissues were weighed and homogenized in 2.5 (100 ll/40 mg wet tissue) or 0.5 (2 ml/mg wet tissue weight) volumes of 0.4 M HClO 4, respectively, then centrifuged at 10,0009g for 5 minutes. Supernatants were filtered through 0.22-lm Millipore membranes (Tullagreen, Carrightwohill CO. Cork, IRL), and 100-ll (cerebellum) or 25-ll (liver) aliquots were injected into a reverse-phase high-pressure liquid chromatography column (Symmetry C18 4.6 9 250 nm; Waters, Milford, MA). The mobile phase consisted of 3 solvents: solvent A, 40 mM NaH 2 PO 4 and 8 mM 1-octanesulfonic acid sodium salt adjusted to pH 3.0 with H 3 PO 4 ; solvent B, 40% methanol in solvent A; and solvent C, 100% methanol. The column was equilibrated with solvent A at a flow rate of 1 ml/ min; after sample injection (100 or 25 ll), separation was obtained using a multistep gradient: 45 minutes at the equilibration conditions, up to 50% solvent B in 1 minute and maintained for 8 minutes, up to 100% solvent B in 30 seconds and maintained for 16.5 minutes, then down to 50% solvent B and 50% solvent C in 1 minute and maintained for 10 minutes to wash and return to equilibration condition for a minimum of 30 minutes before subsequent injections.
Standards
SAM chloride dihydrochloride and SAH obtained from SigmaAldrich (St. Louis, MO) were dissolved in water and diluted with 0.4 M HClO 4 to the final concentration used for high-performance liquid chromatography (HPLC) analysis. Aliquots (100 ll) of the standard solutions were injected onto the HPLC column, and retention times for SAH and SAM were 17.2 minutes and 21.1 minutes, respectively. Five-point calibration curves for SAM and SAH were linear in the range of 25 to 800 ng of the respective standards.
Statistical Analysis
Data were analyzed using 1-way analysis of variance (ANOVA), and group comparisons were performed using the Duncan multiple range test. Significance was set at p < 0.05 for all experiments.
RESULTS
Effects of Chronic EtOH Exposure and Withdrawal on Various Key Steps of the One-Carbon Metabolism in the Cerebellum
To examine the effects of chronic EtOH exposure and its withdrawal on the expression levels of key enzymes of onecarbon metabolism (Fig. 1) , we measured relative mRNA expression for Mat2a and 2b, Ms, Ahyc, Mthfr, and Bhmt. We found that chronic EtOH exposure resulted in a 45% decrease in Ms, 70% increase in Ahyc, and almost 2-fold increase in Mat2b and Mat2b mRNA expressions in the cerebellum, whereas the expression levels for Mthfr and Bhmt were not significantly changed ( Fig. 2A) . While the changes in Ms, Ahyc, and Mat2a returned to normal levels during EtOH withdrawal, the changes in Mat2b remained significantly elevated in this group. In addition, we show that the expression levels for the DNA transmethylation enzymes Dnmt1, Dnmt3a, and Dnmt3b were not changed by chronic EtOH exposure and its withdrawal ( Fig. 2A) .
We also examined whether there was any association between the alteration of the enzymes of one-carbon metabolism with SAM and SAH levels in cerebellum. The results of 
this measurement show that the levels of SAM are approximately 22-fold higher than those of SAH. In addition, chronic EtOH exposure resulted in a 35% decrease in SAH levels and a significant increase in the SAM/SAH ratio with no changes in SAM levels (Fig. 2B) . Additionally, the changes in SAH levels and the SAM/SAH ratio returned to near-normal levels during EtOH withdrawal.
Effects of Chronic EtOH Exposure and Withdrawal on Various Key Steps of One-Carbon Metabolism in Liver
To examine whether the chronic EtOH exposure paradigm used here elicits similar changes in the liver that have previously been reported (Tsukamato and Lu, 2001 ), we also measured the levels of SAM and SAH, determined SAM/SAH ratio and the relative mRNA expression of Mat2a and 2b, Ms, Mthfr, Ahyc, and Bhmt in liver. We show here that chronic EtOH exposure significantly increased Mat2b expression without changing the expression of Mat2a (Fig. 3A) . In addition, and as observed in cerebellum, this chronic EtOH exposure paradigm also produced a significant decrease in Ms expression but did not change the expression of Ahyc which was increased by 70% in cerebellum. In contrast to the changes observed in the cerebellum, chronic EtOH feeding elicited a 30% and 20% decrease in the mRNA expression levels of Mthfr and Bhmt, respectively. In contrast to the cerebellum, all the perturbations of the one-carbon metabolism elicited by chronic EtOH exposure were sustained during withdrawal (Fig. 3A vs. Fig. 2A ). As previously reported (Erman et al., 2004; Halsted et al., 1996; Purohit et al., 2007; Tsukamato and Lu, 2001 ), we also confirmed here that this chronic EtOH exposure paradigm results in a 35% decrease in the levels of SAM and a 40% decrease in the SAM/SAH ratio (Fig. 3B) . In addition, the levels of SAM are approximately 4-fold higher than those of SAH. Compared to the cerebellum, the levels of SAM are 2-to 3-fold higher, while the levels of SAH are about 15-to 17-fold higher in the liver. Whereas chronic EtOH exposure only produced a 10% increase in the levels of SAH, the levels decreased by 20% during withdrawal without a significant change in the SAM/SAH ratio, contrasting with the changes found in cerebellum.
DISCUSSION
The main objective of our study was to examine the effects of long-term EtOH exposure and withdrawal on SAM and SAH levels, the resulting SAM/SAH ratio, and the expression of key enzymes that regulate the availability of SAM (Fig. 1) in the cerebellum and compare these changes to onecarbon metabolism in the liver. We not only confirmed that, in liver, chronic EtOH exposure decreased Ms expression, SAM levels, and the SAM/SAH ratio but also extended these findings and observed that chronic EtOH exposure decreased Mthfr and Bhmt expressions and increased Mat2b expression in the liver. Interestingly, chronic EtOH exposure decreased the levels of SAH and increased the SAM/SAH ratio and the expression of Mat2a and Ahyc without changing the levels of SAM and Bhmt expression in the cerebellum. However, in both liver and cerebellum, chronic EtOH exposure decreased Ms expression and increased Mat2b expression. Furthermore, with the exception of liver Bhmt expression, all these changes returned to near-normal levels during EtOH withdrawal.
Outcomes of human and animal studies suggest that differing degrees of chronic alcohol-induced liver injury are associated with impairment of Ms activity which leads to decreased hepatic concentrations of SAM and folate but increased plasma homocysteine concentrations and hepatic SAH levels (Barak et al., 2003; Cravo et al., 1996; Halsted et al., 1996; Ji and Kaplowitz, 2003; de la Vega et al., 2001 ). Moreover, SAM or betaine supplementation has been shown to prevent alcoholic liver injury in animal studies (Ji and Kaplowitz, 2003; Ji et al., 2008; Song et al., 2003) . It has been demonstrated that SAM and betaine exert protective Values are represented as mean AE SEM of n = 6 rats per group; p < 0.05 1-way ANOVA followed by Duncan multiple range test. *,#p < 0.05. action against chronic alcohol-induced liver injury by several mechanisms including the down-regulation of tumor necrosis factor, the up-regulation of interleukin-10 synthesis, attenuation of oxidative stress by restoring glutathione concentrations and increasing SAM/SAH ratio (Barve et al., 2006; Fernandez-Checa et al., 2002; Ishii et al., 2003; Ji et al., 2008; Jung et al., 2013; Song et al., 2003; Villanueva et al., 2007; Yang et al., 2004) . Thus, one can infer that chronic alcohol-induced liver injury is partly mediated by perturbation of key steps of the one-carbon metabolism (Fig. 1) . For the first time, our data demonstrates that chronic alcohol exposure also modifies one-carbon metabolism in the cerebellum, suggesting that one-carbon metabolism in both the liver and brain may contribute to the pathophysiology of alcoholism.
While chronic EtOH exposure resulted in a significant decrease in Ms expression in both brain and cerebellum, Bhmt and Mthfr expressions were significantly decreased in the liver but remain unchanged in cerebellum. It has been suggested that under normal conditions, alcohol-induced reduction of Ms activity leads to a reduction of SAM levels and enhances the production of SAH and homocysteine in hepatocytes. To compensate for the reduction of Ms activity, Bhmt activity is induced after alcohol consumption. However, after extended periods of alcohol exposure, this compensatory mechanism is not maintained (Varela-Rey et al., 2013) , consequently leading to a reduction of SAM levels, an increase levels of homocysteine and SAH, and a reduced SAM/SAH ratio (Varela-Rey et al., 2013) . These alterations of one-carbon metabolism in the liver may contribute to the reduced hepatic SAM levels observed in patients hospitalized for alcohol-related hepatitis (Lee et al., 2004) . The results of our study suggest that the normal compensatory mechanism that is triggered by a reduction of Ms activity in the liver is nonfunctional after chronic alcohol exposure, whereas in the cerebellum, this compensatory pathway might still be intact. In addition, our finding of chronic EtOH-induced decreases in Ahyc mRNA expression (Fig. 3A) is in agreement with the published finding of Villanueva and Halsted (2004) and is a plausible explanation for the significant decreases in SAH and SAM levels in liver but not cerebellum. In contrast to the liver, the significant increase in Ahyc mRNA expression level in cerebellum ( Fig. 2A ) correlates with the decreased SAH level in cerebellum (Fig. 2B ) and may account for the increased SAM/SAH ratio in cerebellum. This is a reasonable inference because in the one-carbon cycle, Ahyc reversibly hydrolyzes SAH and releases homocysteine and adenosine as end products (Fig. 1) . Under normal physiological condition, homocysteine is utilized by Ms for the biosynthesis of methionine and, in this case, Ahyc-mediated hydrolysis favors the rapid metabolism of SAH into homocysteine and adenosine. However, chronic EtOH-induced accumulation of homocysteine and adenosine (Villanueva and Halsted, 2004) drives the reversible synthesis of SAH (Fig. 1) . Although in the present study, we did not include measurement of Mat1a mRNA expression, chronic EtOHinduced decreases in transcript levels of Mat1a in the liver have been reported previously (Lu et al., 2000; Villanueva and Halsted, 2004) and may also account for the significantly decreased SAM level in the liver (Fig. 3B) . Altogether, these results allow us to speculate that chronic EtOH-induced alterations of one-carbon metabolism and the levels of SAM and SAH in liver and cerebellum might differentially regulate DNA methylation mechanisms during alcoholism.
As depicted in Fig. 1 , methionine is converted to SAM in a reaction catalyzed by Mat (1a and 1b are predominantly expressed in the liver, while 2a and 2b are ubiquitously expressed). Thus, the availability of SAM for transmethylation reactions is regulated by one-carbon metabolism. Dnmts, glycine N-methyltransferase, and other transmethylation enzymes transfer a methyl group from SAM to a large variety of acceptor substrates (DNA, RNA, enzymes, proteins, etc.) and release SAH as a by-product. SAH in turn acts as potent competitive allosteric inhibitor of Mat (1a, 1b, 2a, and 2b) and other transmethylation reactions, and the activity of methyltransferases depends not only on the availability of SAM but also on the cellular concentrations of SAH. Furthermore, SAH cellular concentration depends on the activity of Ahyc which reversibly hydrolyzes SAH into homocysteine plus adenosine (Fig. 1) . Ultimately, the cellular methylation capacity or potential depends on the SAM/ SAH ratio (also known as "methylation index"). Interestingly, it is well established that the Mat2b (regulatory) subunit regulates the activity of the Mat2a (catalytic) subunit by reducing its K m for L-methionine and also rendering it more susceptible to feedback inhibition by SAH (LeGros et al., 2001) . Hence, the findings presented here suggest that a decrease in the SAM/SAH ratio or SAM levels in the liver might lead to decreased transmethylation reactions or DNA hypomethylation (Tsukamato and Lu, 2001 ). In fact, it has been hypothesized that the reduction of SAM availability or the decrease in the SAM/SAH ratio leads to a reduction of hepatic methylation capacity resulting to the characteristic hallmark features that have been associated with chronic alcohol-induced liver injury (Varela-Rey et al., 2013) . In contrast, we can infer that the increase in the SAM/SAH ratio or decrease in SAH found in the cerebellum of chronic EtOH-exposed animals may lead to increased local DNA methylation patterns (hypermethylation) and other transmethylation reactions particularly in cerebellar Purkinje cells, granular cells, and other cellular structures. These changes in cellular methylation capacity might serve as a protective mechanism to preserve these cellular components from chronic alcohol-induced oxidative stress, mitochondrial damage, and inhibition of DNA repair processes (Seitz and Stickel, 2007) .
In a recent study that examined the expression of Mat2b in human postmortem brain, Ponomarev and colleagues (2012) reported a down-regulation of Mat2b mRNA in postmortem cortex and the central and basolateral amygdala of human alcoholics. Although the levels of SAM and SAH were not measured in this study, based on the results of Blasco and colleagues (2005) the authors concluded that the down-regulation of Mat2b may be responsible for the decreased SAM levels seen in human postmortem tissue. This inference was based on the premise that Mat2b changes the kinetic properties of Mat2a, thereby rendering it more susceptible to product inhibition by SAM. If this was the case, decreased expression of Mat2b would render Mat2a less susceptible to product inhibition by SAM and thus lead to increased SAM levels. In contrast, we show here that in liver tissue of rats exposed to chronic alcohol, increased expression of Mat2b is associated with decreased levels of SAM and increased levels of SAH. Perhaps, the increased expression of Mat2b reduces the K m of Mat2a for methionine and renders it more susceptible to feedback inhibition by SAH (De Cabo et al., 1994; Fu et al., 2000; LeGros et al., 2001; Mato et al., 2002; Varela-Rey et al., 2013) . However, it will be important to establish in future studies whether the differential changes in the "methylation index" we observed in brain, specifically the cerebellum, correlate with differences in the level of DNA methylation of target genes in the same tissue. In addition, we will also investigate whether the effects of chronic EtOH exposure on one-carbon metabolism and the "methylation index" in the cerebellum are also present in other brain areas or are specific to the cerebellum.
In conclusion, we demonstrated here that while chronic EtOH exposure decreased SAM levels and SAM/SAH ratio in the liver, it decreased SAH levels and increased SAM/ SAH ratio in the cerebellum. These results indicate a decrease and an increase in "methylation index" in the liver and cerebellum, respectively. The tissue-specific effects of chronic alcohol exposure on the "methylation index" suggest a decrease and an increase in DNA methylation (hypomethylation and hypermethylation) in the liver and cerebellum, respectively. Taken together, our findings clearly implicate impaired methylation mechanisms due to altered one-carbon metabolism in the pathophysiology of alcoholism.
